Table 1.
Noncoding-RNAs | Samples/cells | Expression change | Function | Effects in GO | References |
---|---|---|---|---|---|
miR-146a | Plasma | Downregulation | Promote the differentiation of Th17 cell | Pro-inflammatory | (62) |
CD4+ T | Downregulation | Increase Th1 response | Pro-inflammatory | (63, 64) | |
Orbital tissue | Upregulation | Increase the IL-6 level | Exacerbate GO | (69) | |
Orbital tissue | Upregulation | Decreases FN, collagen Iα, and α -SMA | Inhibit fibrosis process | (72, 73) | |
miR-183 and miR-96 | CD4+ T | Upregulation | Contribute to the activation of CD4+ T cells | Pro-inflammatory | (66) |
miR-21-5P | Orbital tissue | Upregulation | Promote collagen Iα and total collagen production | Promote fibrogenesis | (76) |
miR-146a and miR-155 | Orbital tissue | Upregulation | Reducing the expression of PTEN and ZNRF3 | Promote proliferation | (70) |
m iR-27a and miR-27b | Orbital tissue | Downregulation | Cause the adipogenic differentiation of OFs | Promote adipogenesis | (79) |
m iR-130a | Orbital tissue | Upregulation | Enhance lipid accumulation | Fatty tissue accumulation | (78) |
circRNA_14940 | Orbital tissue | Upregulation | Regulate the Wnt signaling pathway, ECM receptor interaction and PIK3-AKT signaling pathway | Participate in the pathogenesis of GO | (80) |